| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |